New method of therapeutic use of Bauhinia sp. applied in generalized anxiety

摘要

"New modality of therapeutic use of Bauhinia sp. applied in generalized anxiety." The generalized anxiety (GA) affects adults, children, and adolescents.It is associated with the increase of appetite, smoking, alcoholism, aggression, physical diseases (cardiovascular, viral hepatitis, diabetes, chronic pulmonary disease),Causing significant socio-economic losses.The benzodiazipu00ednicos, tricyclic antidepressants and SSRIs have limited or inconclusive action, without any effect in 1 / 3 of the patients and have serious side effects.Potentially fatal as chemical dependency, cardiotoxicity, lethality in overdose, anticholinergic effects, painful ejaculation, weight gain, sexual dysfunction, immunosuppression.Etc. the anxiolytic action occurs 2 - 8 weeks after the start of treatment.It is not known if the cause of the Ag, however the AG is a symptom of autoimmune disease, that is,Chronically high levels of cytokines is progressively induce mental and physical disorders, commonly associated with infections.This patent relates to a new method of use for the Bauhinia sp. used in Ag in which highlights the application of this drug with reasons in immunological technique in combination with antIbioticoterapia, where the medicine is presented as an immunomodulator, reducing those pathologically increased levels of cytokines.With the normalization of the immune system and simultaneous treatment and / or prevention of serious complications and fatal, with minimal side effects or void, showing greater simplicity.The efficiency and effectiveness of the technique in the treatment of immune restorative practice AG, which occurs in the anxiolytic action 1 ^ ^. 30 minutes.The new invention refers to the use of bauhina SP in the Ag, such as: 1. Immunomodulator; 2. Use in the Ag with impressive results, 3. No side effects - use unqualified; 4.Doses above the usual; 5. The association with antibiotic therapy.